Recruiting Thrombocytopenia Studies in Aurora
About Thrombocytopenia Clinical Trials in Aurora
Thrombocytopenia is a condition characterized by abnormally low levels of platelets, which help blood clot. Immune thrombocytopenia (ITP) is a common autoimmune cause. Treatment may include corticosteroids, immunoglobulins, thrombopoietin receptor agonists, and splenectomy.
There are currently 3 thrombocytopenia clinical trials recruiting participants in Aurora, CO. These studies are seeking a combined 2,552 participants. Research is being sponsored by NICHD Neonatal Research Network, argenx, Janssen Research & Development, LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Thrombocytopenia Clinical Trials in Aurora — FAQ
Are there thrombocytopenia clinical trials in Aurora?
Yes, there are 3 thrombocytopenia clinical trials currently recruiting in Aurora, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Aurora?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.
Are clinical trials in Aurora free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.
What thrombocytopenia treatments are being tested?
The 3 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for thrombocytopenia.
Data updated October 12, 2026 from ClinicalTrials.gov